PHGN34 Stock Overview
Operates as a health technology company in North America, the Greater China, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Koninklijke Philips N.V. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €154.88 |
| 52 Week High | €183.41 |
| 52 Week Low | €97.50 |
| Beta | 0.78 |
| 1 Month Change | 3.46% |
| 3 Month Change | -8.25% |
| 1 Year Change | 38.72% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 64.35% |
Recent News & Updates
Recent updates
Shareholder Returns
| PHGN34 | BR Medical Equipment | BR Market | |
|---|---|---|---|
| 7D | -2.8% | -2.8% | -7.2% |
| 1Y | 38.7% | 8.2% | -11.5% |
Return vs Industry: PHGN34 exceeded the BR Medical Equipment industry which returned 8.2% over the past year.
Return vs Market: PHGN34 exceeded the BR Market which returned -11.5% over the past year.
Price Volatility
| PHGN34 volatility | |
|---|---|
| PHGN34 Average Weekly Movement | 7.1% |
| Medical Equipment Industry Average Movement | 7.0% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in BR Market | 9.2% |
| 10% least volatile stocks in BR Market | 2.7% |
Stable Share Price: PHGN34's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: Insufficient data to determine PHGN34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1891 | 68,701 | Roy Jakobs | www.philips.com |
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Koninklijke Philips N.V. Fundamentals Summary
| PHGN34 fundamental statistics | |
|---|---|
| Market cap | R$147.36b |
| Earnings (TTM) | -R$3.06b |
| Revenue (TTM) | R$117.65b |
1.3x
P/S Ratio-48.2x
P/E RatioIs PHGN34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHGN34 income statement (TTM) | |
|---|---|
| Revenue | €18.04b |
| Cost of Revenue | €10.43b |
| Gross Profit | €7.61b |
| Other Expenses | €8.08b |
| Earnings | -€469.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 11, 2025
| Earnings per share (EPS) | -0.50 |
| Gross Margin | 42.18% |
| Net Profit Margin | -2.60% |
| Debt/Equity Ratio | 69.4% |
How did PHGN34 perform over the long term?
See historical performance and comparisonDividends
3.1%
Current Dividend Yieldn/a
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 13:10 |
| End of Day Share Price | 2024/12/16 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Koninklijke Philips N.V. is covered by 54 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Wim Gille | ABN AMRO Bank N.V. |
| Sumit Sayal | AlphaValue |
| Fabrizio Spagna | Axia Financial Research |